Vivaldi Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.25M	Sell	2,542 -116	-4%	-$63K	0.17%	97
2025 Q4	$1.54M	Buy	2,658 +193	+8%	+$109K	0.21%	88
2025 Q3	$1.2M	Buy	2,465 +17	+0.7%	+$7.91K	0.17%	100
2025 Q2	$993K	Sell	2,448 -36	-1%	-$15.1K	0.15%	106
2025 Q1	$1.24M	Sell	2,484 -52	-2%	-$28.2K	0.2%	95
2024 Q4	$1.48M	Buy	2,536 +215	+9%	+$118K	0.23%	83
2024 Q3	$1.44M	Buy	2,321 +17	+0.7%	+$10.1K	0.42%	53
2024 Q2	$1.27M	Buy	2,304 +32	+1%	+$18.3K	0.36%	65
2024 Q1	$1.35M	Buy	2,272 +247	+12%	+$139K	0.39%	64
2023 Q4	$1.09M	Sell	2,025 -197	-9%	-$95.4K	0.33%	81
2023 Q3	$1.12M	Sell	2,222 -185	-8%	-$98.6K	0.37%	72
2023 Q2	$1.26M	Buy	2,407 +236	+11%	+$127K	0.39%	64
2023 Q1	$1.25M	Sell	2,171 -170	-7%	-$95.8K	0.38%	64
2022 Q4	$1.28M	Buy	2,341 +25	+1%	+$13.2K	0.32%	81
2022 Q3	$1.21M	Sell	2,316 -14	-0.6%	-$7.83K	0.33%	72
2022 Q2	$1.27M	Buy	2,330 +1	+0%	+$550	0.33%	72
2022 Q1	$1.26M	Sell	2,329 -103	-4%	-$59.2K	0.33%	73
2021 Q4	$1.62M	Buy	2,432 +3	+0.1%	+$1.87K	0.38%	61
2021 Q3	$1.39M	Sell	2,429 -78	-3%	-$42.8K	0.3%	70
2021 Q2	$1.36M	Buy	2,507 +3	+0.1%	+$1.42K	0.27%	72
2021 Q1	$1.15M	Sell	2,504 -208	-8%	-$99.3K	0.23%	83
2020 Q4	$1.26M	Sell	2,712 -327	-11%	-$153K	0.27%	83
2020 Q3	$1.49M	Sell	3,039 -134	-4%	-$55.4K	0.33%	69
2020 Q2	$1.32M	Sell	3,173 -868	-21%	-$291K	0.28%	76
2020 Q1	$1.15M	Sell	4,041 -598	-13%	-$189K	0.26%	74
2019 Q4	$1.51M	Sell	4,639 -3,265	-41%	-$990K	0.36%	61
2019 Q3	$2.3M	Buy	7,904 +1,783	+29%	+$511K	0.55%	45
2019 Q2	$1.8M	Sell	6,121 -3,656	-37%	-$1.01M	0.47%	48
2019 Q1	$2.68M	Buy	9,777 +7,897	+420%	+$1.97M	0.74%	35
2018 Q4	$421K	Buy	+1,880	New	+$441K	0.18%	104